RedChip Companies
|
|
Weekly Newsletter
|
|
|
Rail Vision Receives $500,000 Order from a Leading Latin America Mining Company
|
Rail Vision (Nasdaq: RVSN), a technology company that is seeking to revolutionize railway safety and the data-related market, received a $500,000 purchase order for a single MainLine system and related services from a leading Latin American (LATAM) mining company. This MainLine system is expected to be delivered to the new customer during the fourth quarter of 2023.
"We have now expanded our global footprint into the massive LATAM market with this purchase order from a leading multinational mining company," said Shahar Hania, CEO of Rail Vision. "This is the second major mining company to use Rail Vision's innovative AI-enabled obstacle detection solutions, strengthening our foothold in an attractive market segment. We are confident that our MainLine system will bring significant value to this customer by enhancing their safety and operational efficiency.”
For more information, visit www.railvision.io
|
BioVie to Present Blinded Data on NE3107 in the Treatment of Mild to Moderate Alzheimer’s Disease at CTAD
BioVie (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today announced that blinded data on cognitive, biomarker, and imaging findings from the recently completed Phase 3 clinical trial (NCT04669028) of NE3107 in the treatment of mild to moderate Alzheimer’s Disease will be presented during an oral presentation at the upcoming 16th Clinical Trials on Alzheimer's Disease (CTAD), to be held in Boston, MA from October 24-27, 2023.
|
60 Degrees Pharma to Present Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting in Boston
60 Degrees Pharmaceuticals (Nasdaq: SXTP), a pharmaceutical company focused on developing new medicines for infectious diseases, will present a poster titled, “Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen, a 12-month, randomized double-blind placebo-controlled trial” at the International Lyme & Associated Diseases Society (ILADS) annual conference in Boston on October 21, 2023. The poster will be presented by 60 Degrees Pharmaceuticals Chief Executive Officer, Geoff Dow, PhD.
|
|
|
Professor Mike Gorley From UK Atomic Energy Authority to Join Board of Directors of ASP Isotopes
ASP Isotopes (Nasdaq: ASPI), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes for use in multiple industries, today announced that Professor Mike Gorley, Chief Technologist at the UK Atomic Energy Authority is to join the board of directors of the Company.
|
Genius Group Board Implements 10-Year Performance Plan for CEO to Achieve $1 Billion Market Capitalization
Genius Group (NYSE American: GNS), a leading entrepreneur edtech and education group, announces today that its Board has approved a 10 year performance plan for the Founder & CEO, Roger James Hamilton, to earn share awards across 10 tranches based on achieving market capitalization targets for Genius Group up to $1 billion within 10 years or less.
|
|
|
Small Stocks Big Money™ Podcasts
|
|
|
Upcoming Events |
|
|
|
|
| NASDAQ: RVSN - Rail Vision |
| 11:00am Eastern |
| Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. |
|
|
|
|
|
| NASDAQ: GENE - Genetic Technologies Limited |
| 4:15pm Eastern |
| Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
Archive Events |
|
|
|
|
| NASDAQ: AREC - American Resources |
| Meeting Duration 49 minutes |
| American Resources Corp. is building one of the most unique growth platforms to strategically align old-world, legacy assets with a more modern economy. |
|
|
Lesson of the Week
Buy when no one else is looking.
|
|
|
MidSouth Week in Review
Social Security is increasing 3.2% in 2024 which is a higher number than the 2.6% average over the past 20 years.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
|
© 2023 RedChip , All rights reserved
|
|
| |
|
|
